Literature DB >> 14678280

Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis.

O Vittecoq1, B Incaurgarat, F Jouen-Beades, J Legoedec, O Letourneur, D Rolland, G Gervasi, J F Ménard, A Gayet, P Fardellone, A Daragon, M Jolivet, X le Loët, F Tron.   

Abstract

The objective of the study was to determine the diagnostic value for rheumatoid arthritis (RA) of anti-filaggrin autoantibodies (autoAb) recognizing citrullinated recombinant rat filaggrin (ACRF) in community cases of very early arthritis. To evaluate the diagnostic value of ACRF, were studied sera from patients with different classified rheumatic diseases and healthy subjects (group 1, n= 422) and 314 community cases of very early arthritis (group 2) that were classified as RA (n = 176), non-RA (n = 63) and undifferentiated (n = 75) arthritides after 1 years of follow-up. ACRF were measured using a new ELISA, with results expressed as the difference between the OD value obtained on citrullinated minus that on noncitrullinated rat filaggrin (differential ACRF; dACRF). For both groups, rheumatoid factors (RF), anti-keratin autoAb (AKA) and anti-perinuclear factor (APF) were tested; for group 2, anti-CCP autoAb were also tested. Different reactivity patterns against citrullinated and noncitrullinated filaggrin were observed. Almost all sera reacting with citrullinated but not noncitrullinated filaggrin were from RA patients. Among RA and non-RA sera that recognized both forms of filaggrin, a positive result was obtained only with RA sera. For groups 1 and 2, dACRF sensitivity was 58.4% and 30.7%, and specificity for RA was 99.5% and 98.4%, respectively. In group 2, dACRF specificity for RA was better than that of RF (92.1%), APF (95.2%), AKA (96.8%) and anti-CCP (95.2%). dACRF positive predictive value was high (98.2) and close to that given by the concomitant positivity of RF and anti-CCP autoAb. Despite a high positive correlation between AKA, APF, anti-CCP and dACRF test results, they were complementary since some sera were positive for only one test. Thus, in a community setting, anti-citrullinated rat filaggrin reactivity detected by a new ELISA, whose originality is based on the difference between serum's reactivities on the citrullinated and native forms of filaggrin, had a higher diagnostic value for RA than other autoAb.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678280      PMCID: PMC1808924          DOI: 10.1111/j.1365-2249.2004.02341.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Antifilaggrin antibodies in recent-onset arthritis.

Authors:  K Aho; T Palosuo; M Lukka; P Kurki; H Isomäki; H Kautiainen; R von Essen
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

Review 2.  Insights into rheumatoid arthritis derived from the Sa immune system.

Authors:  H A Ménard; E Lapointe; M D Rochdi; Z J Zhou
Journal:  Arthritis Res       Date:  2000-08-17

3.  The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.

Authors:  E Girbal-Neuhauser; J J Durieux; M Arnaud; P Dalbon; M Sebbag; C Vincent; M Simon; T Senshu; C Masson-Bessière; C Jolivet-Reynaud; M Jolivet; G Serre
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

4.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

5.  Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay.

Authors:  T Palosuo; M Lukka; H Alenius; N Kalkkinen; K Aho; P Kurki; R Heikkilä; M Nykänen; R von Essen
Journal:  Int Arch Allergy Immunol       Date:  1998-04       Impact factor: 2.749

6.  Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis.

Authors:  H Visser; L B Gelinck; A H Kampfraath; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

Review 7.  Prognostic factors in early rheumatoid arthritis.

Authors:  D L Scott
Journal:  Rheumatology (Oxford)       Date:  2000-06       Impact factor: 7.580

8.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

9.  Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care.

Authors:  I E van der Horst-Bruinsma; I Speyer; H Visser; F C Breedveld; J M Hazes
Journal:  Br J Rheumatol       Date:  1998-10

10.  Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.

Authors:  V Cheynet; B Verrier; F Mallet
Journal:  Protein Expr Purif       Date:  1993-10       Impact factor: 1.650

View more
  26 in total

Review 1.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

Review 2.  Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance.

Authors:  M Kristen Demoruelle; Kevin Deane
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

3.  Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.

Authors:  Sevil Kamali; Nuray Gurel Polat; Esen Kasapoglu; Ahmet Gul; Lale Ocal; Orhan Aral; Meral Konice; Selim Badur; Murat Inanc
Journal:  Clin Rheumatol       Date:  2005-05-31       Impact factor: 2.980

4.  Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.

Authors:  Xue-Ping Wang; Qian-Yao Cheng; Ming-Ming Gu; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2019-02-27       Impact factor: 2.980

Review 5.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

6.  The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.

Authors:  Hee Jung Ryu; Fujio Takeuchi; Shoji Kuwata; Yoon Jun Kim; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

7.  Association of anti-CCP positivity with serum ferritin and DAS-28.

Authors:  Burcu Önder; Aydan Kurtaran; Songül Kimyon; Barin Selçuk; Müfit Akyüz
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

8.  Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection.

Authors:  Howaida E Mansour; Khaled M Metwaly; Iman A Hassan; Hebat-Allah A Elshamy; Moataz M S Elbeblawy
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-05-24

9.  Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy.

Authors:  Wafaa M Ezzat; Hala M Raslan; Azza A Aly; Nahed A Emara; Manal M El Menyawi; Amr Edrees
Journal:  Rheumatol Int       Date:  2009-11-01       Impact factor: 2.631

10.  A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.

Authors:  Lisiane Maria Enriconi dos Anjos; Ivanio Alves Pereira; Eleonora d 'Orsi; Andrea Piette Seaman; Rufus Watson Burlingame; Edelton Flavio Morato
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.